Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
pfizer
4
×
president trump
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
astrazeneca
biogen
bristol-myers squibb
medicare
novartis
sarepta therapeutics
albert bourla
alzheimer's disease
amgen
cancer immunotherapy
What
bio
drug
roundup
biotech
prices
seven
today
acquisitions
albert
alzheimer’s
annual
assessed
attention
august
away
biggest
bourla
bringing
busy
ceo
ceos
communities
company
conference
crispr
days
dc
decisions
devices
drugs
esmo
europe
executives
fda
future
gathered
germany
groups
hearing
held
Language
unknown
unset
Current search:
pfizer
×
abbvie
×
" president trump "
×
national
×
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More